Abhishek Jain

CIK 1931277 · View on SEC EDGAR ↗

Insider

First SEC filing: March 2, 2026 · Latest: March 2, 2026

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 14 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
May 27, 2025 CDNA F 1,982 $17.63 $34,943 327,412 Direct -0.60% Disposed 162.8% (price as of 2026-08-21)
May 1, 2025 CDNA F 7,686 $15.07 $115,828 329,394 Direct -2.28% Disposed 207.5% (price as of 2026-08-21)
April 8, 2024 CDNA F 235 $9.53 $2,240 293,377 Direct -0.08% Disposed 386.2% (price as of 2026-08-21)
Feb. 1, 2024 CDNA A 174,520 293,612 Direct +146.54% Acquired (price as of 2026-08-21)
Feb. 1, 2024 CDNA F 11,469 $8.88 $101,845 119,092 Direct -8.78% Disposed 421.8% (price as of 2026-08-21)
Sept. 7, 2023 CDNA F 2,746 $8.26 $22,682 130,561 Direct -2.06% Disposed 461.0% (price as of 2026-08-21)
Sept. 6, 2023 CDNA F 1,054 $8.81 $9,286 133,307 Direct -0.78% Disposed 425.9% (price as of 2026-08-21)
May 26, 2023 CDNA F 1,297 $7.96 $10,324 132,109 Direct -0.97% Disposed 482.1% (price as of 2026-08-21)
April 18, 2023 CDNA F 221 $9.07 $2,004 133,406 Direct -0.17% Disposed 410.9% (price as of 2026-08-21)
April 6, 2023 CDNA F 173 $8.81 $1,524 133,627 Direct -0.13% Disposed 425.9% (price as of 2026-08-21)
Feb. 1, 2023 CDNA A 44,100 44,100 Direct Acquired (price as of 2026-08-21)
Feb. 1, 2023 CDNA A 85,100 133,800 Direct +174.74% Acquired (price as of 2026-08-21)
May 26, 2022 CDNA A 10,000 10,000 Direct Acquired (price as of 2026-08-21)
May 26, 2022 CDNA A 15,000 26,550 Direct +129.87% Acquired (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Feb. 1, 2023 CDNA Stock Option (right to buy) Common Stock (44,100) $15.66 Feb. 1, 2033 44,100 Acquired
May 26, 2022 CDNA Employee Stock Option (right to buy) Common Stock (10,000) $24.07 May 26, 2032 10,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 5 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
March 2, 2026 NEO Stock Option (Right to Buy)→ Common Stock (183,578) 183,578 Direct
March 2, 2026 NEO Restricted Stock Unit→ Common Stock (110,088) 110,088 Direct
May 27, 2022 CDNA Common Stock Direct
May 27, 2022 CDNA Employee Stock Option (right to buy)→ Common Stock (2,550) 2,550 Direct
May 27, 2022 CDNA Employee Stock Option (right to buy)→ Common Stock (1,000) 1,000 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CDNA

CFO
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2024 $411,169 $300,000 $493,403 $8,400 $2,762,710
2023 $405,000 $100,000 $174,300 $8,820 $3,094,707
2022 $318,917 $904,723 $1,013,007 $104,260 $2,400 $2,343,307

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.